tiprankstipranks
Trending News
More News >

Castle Biosciences price target lowered to $37 from $42 at Canaccord

Canaccord lowered the firm’s price target on Castle Biosciences (CSTL) to $37 from $42 and keeps a Buy rating on the shares. The firm said they delivered soid Q1 results and although they remain bullish on the company and believe the shares are undervalued, they recognize there is material risk to the company executing on its growth strategy.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue